DocDollars

Galvanize Therapeutics, Inc

CA · United States · Reporting entity ID 100001176960

Total reported 2019–2025
$8.86M
#530 of 2,960 reporting companies — 0% of all reported industry payments
$815K in general payments across 2,793 records, plus $8.05M in research funding across 394 records.

How it breaks down

General payments $814,903
Research funding $8,048,194

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Galvanize Therapeutics, Inc reported $8.86M to US doctors and teaching hospitals from 2019 to 2025, ranking #530 of 2,960 reporting companies. 91% of that was research funding and 9% general payments such as consulting, speaking, food and travel. 2,793 general payment records and 394 research records were filed.

Common questions about Galvanize Therapeutics, Inc

How much has Galvanize Therapeutics, Inc paid US doctors?

Galvanize Therapeutics, Inc reported $8,863,097 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $814,903 in general payments, $8,048,194 in research funding.

How does Galvanize Therapeutics, Inc rank among drug and device companies?

It ranks #530 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Galvanize Therapeutics, Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.